These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23929731)

  • 1. Examining factors that influence the effectiveness of cleaning antineoplastic drugs from drug preparation surfaces: a pilot study.
    Hon CY; Chua PP; Danyluk Q; Astrakianakis G
    J Oncol Pharm Pract; 2014 Jun; 20(3):210-6. PubMed ID: 23929731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning.
    Chu WC; Hon CY; Danyluk Q; Chua PP; Astrakianakis G
    J Oncol Pharm Pract; 2012 Mar; 18(1):46-51. PubMed ID: 21737485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of decontamination efficacy of cleaning solutions on stainless steel and glass surfaces contaminated by 10 antineoplastic agents.
    Queruau Lamerie T; Nussbaumer S; Décaudin B; Fleury-Souverain S; Goossens JF; Bonnabry P; Odou P
    Ann Occup Hyg; 2013 May; 57(4):456-69. PubMed ID: 23223271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy of additional measures introduced for the protection of healthcare personnel handling antineoplastic drugs.
    Odraska P; Dolezalova L; Kuta J; Oravec M; Piler P; Blaha L
    Ann Occup Hyg; 2013 Mar; 57(2):240-50. PubMed ID: 22926784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device.
    Siderov J; Kirsa S; McLauchlan R
    J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals.
    Hon CY; Teschke K; Chu W; Demers P; Venners S
    J Occup Environ Hyg; 2013; 10(7):374-83. PubMed ID: 23668810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study comparing the efficacy of two cleaning techniques in reducing environmental contamination with cyclophosphamide.
    Touzin K; Bussières JF; Langlois E; Lefebvre M; Métra A
    Ann Occup Hyg; 2010 Apr; 54(3):351-9. PubMed ID: 20118195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleaning Efficiencies of Three Cleaning Agents on Four Different Surfaces after Contamination by Gemcitabine and 5-fluorouracile.
    Böhlandt A; Groeneveld S; Fischer E; Schierl R
    J Occup Environ Hyg; 2015; 12(6):384-92. PubMed ID: 25751496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The assessment of environmental and external cross-contamination in preparing ready-to-administer cytotoxic drugs: a comparison between a robotic system and conventional manual production.
    Werumeus Buning A; Geersing TH; Crul M
    Int J Pharm Pract; 2020 Feb; 28(1):66-74. PubMed ID: 31489970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of four cleaning solutions for the decontamination of selected cytotoxic drugs on the different surfaces of an automated compounding system.
    Federici M; Raffaelli J; Paolucci D; Schierl R; Krämer I
    J Occup Environ Hyg; 2019 Jan; 16(1):6-15. PubMed ID: 30230976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system.
    Hon CY; Teschke K; Demers PA; Venners S
    Ann Occup Hyg; 2014 Jul; 58(6):761-70. PubMed ID: 24644303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case study: surface contamination of cyclophosphamide due to working practices and cleaning procedures in two Italian hospitals.
    Acampora A; Castiglia L; Miraglia N; Pieri M; Soave C; Liotti F; Sannolo N
    Ann Occup Hyg; 2005 Oct; 49(7):611-8. PubMed ID: 15964876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter evaluation of a new closed system drug-transfer device in reducing surface contamination by antineoplastic hazardous drugs.
    Bartel SB; Tyler TG; Power LA
    Am J Health Syst Pharm; 2018 Feb; 75(4):199-211. PubMed ID: 29339374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Two Cleaning Solutions for the Decontamination of 10 Antineoplastic Agents in the Biosafety Cabinets of a Hospital Pharmacy.
    Anastasi M; Rudaz S; Queruau Lamerie T; Odou P; Bonnabry P; Fleury-Souverain S
    Ann Occup Hyg; 2015 Aug; 59(7):895-908. PubMed ID: 25979920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative LC-MS method to determine surface contamination of antineoplastic drugs by wipe sampling.
    Kåredal M; Jönsson R; Wetterling M; Björk B; Hedmer M
    J Occup Environ Hyg; 2022 Jan; 19(1):50-66. PubMed ID: 34723774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden.
    Hedmer M; Georgiadi A; Bremberg ER; Jönsson BA; Eksborg S
    Ann Occup Hyg; 2005 Oct; 49(7):629-37. PubMed ID: 16126760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of surface contamination in a hospital hematology--oncology pharmacy.
    Touzin K; Bussières JF; Langlois E; Lefebvre M
    J Oncol Pharm Pract; 2009 Mar; 15(1):53-61. PubMed ID: 18772214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a closed system drug-transfer device eliminates surface contamination with antineoplastic agents.
    Clark BA; Sessink PJ
    J Oncol Pharm Pract; 2013 Jun; 19(2):99-104. PubMed ID: 23292973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of cleaning procedures for highly potent drugs. I. Losoxantrone.
    Shea JA; Shamrock WF; Abboud CA; Woodeshick RW; Nguyen LQ; Rubino JT; Segretario J
    Pharm Dev Technol; 1996 Apr; 1(1):69-75. PubMed ID: 9552333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.